Cryoport (CYRX) Cash & Equivalents (2010 - 2026)

Cryoport (CYRX) has 17 years of Cash & Equivalents data on file, last reported at $272.9 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $272.9 million, up 476.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $272.9 million (up 476.24% YoY), and the FY2025 annual result was $250.5 million, up 633.79% from the prior year.
• Cash & Equivalents rose to $272.9 million in Q1 2026 per CYRX's latest filing, from $250.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $272.9 million in Q1 2026 and troughed at $28.9 million in Q3 2022.
• A 5-year average of $95.6 million and a median of $39.3 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents tumbled 89.4% in 2022, then jumped 715.57% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $36.6 million in 2022, then increased by 26.65% to $46.3 million in 2023, then fell by 26.34% to $34.1 million in 2024, then jumped by 633.79% to $250.5 million in 2025, then increased by 8.95% to $272.9 million in 2026.
• Business Quant data shows CYRX's Cash & Equivalents at $272.9 million in Q1 2026, $250.5 million in Q4 2025, and $255.8 million in Q3 2025.